Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Medicare+Choice Bills May Stop Exodus of Plans, But Are Not Likely to Expand Enrollment in HMOs

18.07.2002

As Congress considers legislative proposals aimed at saving Medicare+Choice, a new study published today on the Health Affairs Web site shows that under the best-case scenario, enrollment in the troubled managed care program would stabilize at about 5 million beneficiaries.

Under the worst case of the four policy proposals to boost sluggish M+C reimbursement, enrollment would shrink to just 3.3 million by 2005, according to the article by health care scholars Kenneth E. Thorpe and Adam Atherly.

These findings are important for low and moderate-income beneficiaries, who make up 55 percent of M+C enrollees and rely on M+C plans because they cover drugs and other supplemental benefits. The authors found that M+C plans provided $6 billion in added benefits to enrollees in 2001 when compared to the Medicare fee for service benefit package. If M+C were completely eliminated, the authors write, more than 30 percent would end up with Medicare coverage only, raising the number of beneficiaries with no coverage for drugs and other supplemental services to 6.5 million from 5 million.

The authors analyze M+C payment rates and likely enrollment through 2005 under four different policy options. President Bush’s M+C proposal would yield a stable enrollment, declining from 5.3 million today to about 5 million in 2005. A plan authored by Rep. Nancy Johnson (R-CT), similar to legislation the House of Representatives has already endorsed, would result in a decline of about 1 million enrollees by 2005. A proposal by the Medicare Payment Advisory Commission would cause enrollment to drop by 2 million, to 3.3 million, and current law would result in a 2005 enrollment of 4.1 million.

The authors conclude that the program has been hampered by conflicting policy goals since passage of the Balanced Budget Act of 1997. Policymakers want M+C to reduce health care cost growth, provide a stable supplemental benefits package, and expand into underserved areas. The authors urge policymakers to give more clearly defined and focused expectations if they want M+C to be a major part of Medicare reform in the future.

Health Affairs, published by Project HOPE, is a bimonthly multidisciplinary journal devoted to publishing the leading edge in health policy thought and research.

Project HOPE | EurekAlert
Further information:
http://www.healthaffairs.org/WebExclusives/Thorpe_Web_ Excl_071702.htm

More articles from Health and Medicine:

nachricht Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg

nachricht Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

Black nitrogen: Bayreuth researchers discover new high-pressure material and solve a puzzle of the periodic table

29.05.2020 | Materials Sciences

Argonne researchers create active material out of microscopic spinning particles

29.05.2020 | Materials Sciences

Smart windows that self-illuminate on rainy days

29.05.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>